Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inmaculada Rioja

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
The Journal of Experimental Medicine|March 11, 2018
Signaling function of PRC2 is essential for TCR-driven T cell responsesMarc-Werner Dobenecker, Joon Seok Park, Jonas Marcello, et al.
ACS Infectious Diseases|October 6, 2021
Expanding Bromodomain Targeting into Neglected Parasitic DiseasesCynthia Tallant, Paul Bamborough, Chun-Wa Chung, et al.
ACS Infectious Diseases|April 28, 2022
Essential Bromodomain <i>Tc</i>BDF2 as a Drug Target against Chagas DiseaseAlejandro Pezza, Luis E Tavernelli, Victoria L Alonso, et al.
Frontiers in Endocrinology|September 30, 2022
<i>N-</i>terminal BET bromodomain inhibitors disrupt a BRD4-p65 interaction and reduce inducible nitric oxide synthase transcription in pancreatic β-cellsJoshua A Nord, Sarah L Wynia-Smith, Alyssa L Gehant, et al.
The Journal of Rheumatology|October 5, 2010
Quantitative power Doppler ultrasonography is a sensitive measure of metacarpophalangeal joint synovial vascularity in rheumatoid arthritis and declines significantly following a 2-week course of oral low-dose corticosteroidsMaggie J Larché, Matthew Seymour, Adrian Lim, et al.
Plos Biology|December 10, 2015
Bromodomain Proteins Contribute to Maintenance of Bloodstream Form Stage Identity in the African TrypanosomeDanae Schulz, Monica R Mugnier, Eda-Margaret Paulsen, et al.
Nature Communications|July 13, 2022
Bromodomain factor 5 is an essential regulator of transcription in LeishmaniaNathaniel G Jones, Vincent Geoghegan, Gareth Moore, et al.
Stem Cell Research|September 4, 2016
BET bromodomain inhibition promotes neurogenesis while inhibiting gliogenesis in neural progenitor cellsJingjun Li, Jing Ma, Guofeng Meng, et al.
Journal of Medicinal Chemistry|July 22, 2020
GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) ProteinsRobert J Watson, Paul Bamborough, Heather Barnett, et al.
Molecular Immunology|October 7, 2016
BET bromodomain inhibition reduces maturation and enhances tolerogenic properties of human and mouse dendritic cellsRonald Schilderink, Matthew Bell, Eleonora Reginato, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
The Journal of Experimental Medicine|March 11, 2018
Signaling function of PRC2 is essential for TCR-driven T cell responsesMarc-Werner Dobenecker, Joon Seok Park, Jonas Marcello, et al.
ACS Infectious Diseases|October 6, 2021
Expanding Bromodomain Targeting into Neglected Parasitic DiseasesCynthia Tallant, Paul Bamborough, Chun-Wa Chung, et al.
ACS Infectious Diseases|April 28, 2022
Essential Bromodomain <i>Tc</i>BDF2 as a Drug Target against Chagas DiseaseAlejandro Pezza, Luis E Tavernelli, Victoria L Alonso, et al.
Frontiers in Endocrinology|September 30, 2022
<i>N-</i>terminal BET bromodomain inhibitors disrupt a BRD4-p65 interaction and reduce inducible nitric oxide synthase transcription in pancreatic β-cellsJoshua A Nord, Sarah L Wynia-Smith, Alyssa L Gehant, et al.
The Journal of Rheumatology|October 5, 2010
Quantitative power Doppler ultrasonography is a sensitive measure of metacarpophalangeal joint synovial vascularity in rheumatoid arthritis and declines significantly following a 2-week course of oral low-dose corticosteroidsMaggie J Larché, Matthew Seymour, Adrian Lim, et al.
Plos Biology|December 10, 2015
Bromodomain Proteins Contribute to Maintenance of Bloodstream Form Stage Identity in the African TrypanosomeDanae Schulz, Monica R Mugnier, Eda-Margaret Paulsen, et al.
Nature Communications|July 13, 2022
Bromodomain factor 5 is an essential regulator of transcription in LeishmaniaNathaniel G Jones, Vincent Geoghegan, Gareth Moore, et al.
Stem Cell Research|September 4, 2016
BET bromodomain inhibition promotes neurogenesis while inhibiting gliogenesis in neural progenitor cellsJingjun Li, Jing Ma, Guofeng Meng, et al.
Journal of Medicinal Chemistry|July 22, 2020
GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) ProteinsRobert J Watson, Paul Bamborough, Heather Barnett, et al.
Molecular Immunology|October 7, 2016
BET bromodomain inhibition reduces maturation and enhances tolerogenic properties of human and mouse dendritic cellsRonald Schilderink, Matthew Bell, Eleonora Reginato, et al.
Pageof 5